At a glance
ClinicalIndex Comparison RecordN/ACompleted· 502 enrolled
Drug / intervention
Azithromycin SRdrug
Likely dose
Azithromycin SR 2gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Zithromax-SR 2g, Special Investigation For Skin And Soft Tissue Infection, Sexually-Transmitted Infection, And Infection Of The Oral (Regulatory Post Marketing Commitment Plan)
In Brief
An observational study evaluating Azithromycin SR for Bacterial Infections. Completed, enrolled 502 participants.
Detailed Summary
To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBacterial Infections
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedOct 2009
Primary CompletionJan 2011
TodayJul 2026
First PostedOct 20, 2009
Enrollment StartOct 1, 2009
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.7 years ago
Interventions
Azithromycin SRdrug
Zithromax SR 2g, taking once for treatment.